Diabetes

vTv Therapeutics Drops as Diabetes Study Date Approaches
····

vTv Therapeutics Drops as Diabetes Study Date Approaches

vTv Therapeutics shares fell 1.1% to $33.14 Friday afternoon, underperforming biotech indexes as investors await updates on its diabetes drug cadisegliatin. The company last reported on May 13, saying Phase 3 CATT1 enrollment remains on track for Q3 2026. Cash reserves rose to $98.1 million at March 31 after a $20 million licensing payment. No new filings or press releases have been issued since the quarterly report.
May 29, 2026

Stock Market Today

  • Fuller, Smith & Turner PLC Shares Buyback Update on May 29, 2026
    May 29, 2026, 2:43 PM EDT. Fuller, Smith & Turner PLC (FSTA) repurchased 12,000 of its "A" Ordinary Shares at an average price of 673.55 pence per share on May 29, 2026, through Deutsche Bank AG as part of its ongoing share buyback programme announced in January 2026. The total number of issued shares after the transaction is 33,946,686, with 2,830,811 shares held in Treasury. The voting rights outstanding amount to 31,115,875, which shareholders should use as the denominator for reporting under FCA Disclosure and Transparency Rules. This move signals Fuller's intent to manage shareholder value and return capital. The shares repurchased will be held in Treasury, and transaction details were disclosed under Market Abuse Regulation requirements.